The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages
The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages
复制标题
DOI:
10.1038/ncomms4944
复制
发表时间:
2014-05-01
影响因子:
16.6
通讯作者:
Schwaninger, Markus
中科院分区:
文献类型:
--
作者:
Rahman, Mahbubur;Muhammad, Sajjad;Schwaninger, Markus
The ketone body beta-hydroxybutyrate (BHB) is an endogenous factor protecting against stroke and neurodegenerative diseases, but its mode of action is unclear. Here we show in a stroke model that the hydroxy-carboxylic acid receptor 2 (HCA(2), GPR109A) is required for the neuroprotective effect of BHB and a ketogenic diet, as this effect is lost in Hca2(-/-) mice. We further demonstrate that nicotinic acid, a clinically used HCA(2) agonist, reduces infarct size via a HCA(2)-mediated mechanism, and that noninflammatory Ly-6C(Lo) monocytes and/or macrophages infiltrating the ischemic brain also express HCA(2). Using cell ablation and chimeric mice, we demonstrate that HCA(2) on monocytes and/or macrophages is required for the protective effect of nicotinic acid. The activation of HCA(2) induces a neuroprotective phenotype of monocytes and/or macrophages that depends on PGD(2) production by COX1 and the haematopoietic PGD2 synthase. Our data suggest that HCA(2) activation by dietary or pharmacological means instructs Ly-6C(Lo) monocytes and/or macrophages to deliver a neuroprotective signal to the brain.